Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Analytical Scientist
  • Explore

    Explore

    • Latest
    • News & Research
    • Trends & Challenges
    • Keynote Interviews
    • Opinion & Personal Narratives
    • Product Profiles
    • App Notes

    Featured Topics

    • Mass Spectrometry
    • Chromatography
    • Spectroscopy

    Issues

    • Latest Issue
    • Archive
  • Topics

    Techniques & Tools

    • Mass Spectrometry
    • Chromatography
    • Spectroscopy
    • Microscopy
    • Sensors
    • Data & AI

    • View All Topics

    Applications & Fields

    • Clinical
    • Environmental
    • Food, Beverage & Agriculture
    • Pharma & Biopharma
    • Omics
    • Forensics
  • People & Profiles

    People & Profiles

    • Power List
    • Voices in the Community
    • Sitting Down With
    • Authors & Contributors
  • Business & Education

    Business & Education

    • Innovation
    • Business & Entrepreneurship
    • Career Pathways
  • Events
    • Live Events
    • Webinars
  • Multimedia
    • Video
Subscribe
Subscribe

False

The Analytical Scientist / Power List / 2024 / Instrumental Innovators / Martin Gilar

Martin Gilar

Research Fellow, Separations R&D, Waters Corporation, USA

  • Profile

Meet Martin Gilar

Main research aims? I am fortunate to participate in research of LC instruments, columns, and analytical techniques at Waters. I enjoy developing the methods for analysis of biomolecules such as peptides and oligonucleotides.

An exciting instrumental innovation… For me the most exciting recent improvement was the introduction of MaxPeak High Performance Surfaces (HPS) Technology. HPS is the modification of metal surfaces of LC hardware with hybrid-silica chemistry. It minimizes the interactions of analytes with metal-oxide surfaces in columns and LC hardware, which reduces the non-specific adsorption, peak tailing, and carryover for certain classes of analytes, such as acidic molecules, nucleic acids, and peptides. The improvements I observed with oligonucleotides were remarkable. We published our results in several papers, but the benefits of HPS technology are still not widely known to analysts around the world.

Spending a $1 Billion research grant… As an aspiring SF writer, I am curious about extraterrestrial life. I don’t mean “ET phone home” or little green men, but the origins of life. With a $1 billion research grant, I could apply the proteomic and genomic methods to study the most primitive forms of bacteria, their molecular machinery, and metabolism. The results will be handy in future when we discover (microbial) life on Mars, Jupiter’s moon Europa (I bet life is everywhere). Once we understand the basics, we can advance human life and health on Earth. Sure, the discovery of life in other places would throw a monkey wrench into the human space exploration/colonization programs, but hey, nothing is for free.

Newsletters

Receive the latest pathology news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

False

Advertisement

Recommended

False

False

The Analytical Scientist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.